IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
November 05, 2020 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Adds Three Distinguished Executives to its Board of Directors
November 02, 2020 09:25 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Partners with Safe Balance, LLC to Provide Services that Improve Balance for the Reduction of Fall Risk
September 23, 2020 09:15 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn and BIRMINGHAM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Announces Update to Service Locations
September 15, 2020 09:25 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 15, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Holdings to Present at the LD Micro 500 Virtual Conference on September 1, 2020
August 25, 2020 08:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 25, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Reports Second Quarter 2020 Financial Results
August 14, 2020 09:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 14, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care, specializing in regenerative...
IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
August 05, 2020 11:58 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Regeneration Centers Sells Lexington Property for $1.3M in Sale-Leaseback Transaction
July 27, 2020 10:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Prices $2.65 Million Common Stock Offering
June 18, 2020 08:45 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 18, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Regeneration Centers Analysis Shows 81% of Patients Report Improvement in Functional Outcomes from Treatment of Musculoskeletal Conditions
June 17, 2020 08:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 17, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...